Literature DB >> 26752247

Drug Discontinuation and Follow-up Rates in Oral Antithrombotic Trials.

Thomas A Marciniak1, Vasily Cherepanov2, Elena Golukhova3, Moo Hyun Kim4, Victor Serebruany5.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26752247     DOI： 10.1001/jamainternmed.2015.6769

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  3 in total

1.  Antiplatelet therapy: Aspirin in the elderly - tailored approaches ahead?

Authors:  Victor Serebruany; Elena Golukhova
Journal:  Nat Rev Cardiol       Date:  2017-08-10       Impact factor: 32.419

2.  Oral Anticoagulants and Renal Impairment: The Convoluting Dilemma.

Authors:  Victor Serebruany
Journal:  EBioMedicine       Date:  2016-04-27       Impact factor: 8.143

3.  Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System.

Authors:  Victor Serebruany; Vasily Cherepanov; Seth Fortmann; Moo Hyun Kim
Journal:  Open Heart       Date:  2017-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.